Vaccine News and Research

Latest Vaccine News and Research

Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed

Bio-Matrix Scientific Group, Inc. Chairman & CEO David Koos commented on the Company’s new opportunities in stem cell research, cancer treatment and intellectual property.

1 Sep 2009

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

A team of researchers from The Wistar Institute have shown that a large non-coding RNA in mammals and yeast plays a central role in helping maintain telomeres, the tips of chromosomes that contain important genetic information and help regulate cell division. Since this RNA also facilitates the formation of DNA at telomeres-a process that can protect aging cells and destabilize tumor cells-manipulating its expression may be useful in treating cancer and other diseases.

1 Sep 2009

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).

1 Sep 2009

GenoCAD project receives financial support from NSF

The National Science Foundation (NSF) has awarded a three-year $1,421,725 grant to Jean Peccoud, associate professor at the Virginia Bioinformatics Institute at Virginia Tech, to develop GenoCAD - a web-based Computer Assisted Design environment for synthetic biology.

1 Sep 2009

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

Braasch Biotech LLC announces its lead vaccine for Obesity, Growth Hormone Deficiencies may have beneficial use for numerous IGF-1 responsive disorders such as diabetes, heart disease and Rett Syndrome based on initial preclinical testing in a mouse model.

1 Sep 2009

Gates Foundation appoints new HIV program head

The Bill & Melinda Gates Foundation recently announced that Stefano Bertozzi will head up its HIV programs starting August 31, the Puget Sound Business Journal reports (8/27).

1 Sep 2009

H1N1 cases on decline in Southern Hemisphere, WHO says

The number of H1N1 (swine) flu cases are steadily declining in the Southern Hemisphere as the region's flu season comes to an end, the WHO said Friday, the Associated Press reports (Engeler, 8/29).

1 Sep 2009

Stanford University starts recruiting participants for swine flu vaccine clinical trial

The Stanford University School of Medicine is recruiting participants for a clinical trial to determine the safety of an experimental vaccine against the new H1N1 strain of influenza when the vaccine is combined with an immune-stimulating substance called an adjuvant. The trial will also examine whether use of the adjuvant improves the immune response to the vaccine.

31 Aug 2009

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.

31 Aug 2009

Walgreens to provide flue shots faster and easier this season

Walgreens (NYSE:WAG)(NASDAQ:WAG) is making it faster and easier to get a flu shot this season. The nation’s largest drugstore chain today announced it will begin offering seasonal flu shots on Sept. 1 at more than 7,000 points of care nationwide, including nearly all of its stores in 50 states and almost 350 in-store Take Care Clinics.

31 Aug 2009

Merck undergoes restructuring after Schering-Plough merger

Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. (NYSE: MRK) today announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.

31 Aug 2009

Geron to present updates on product development programs at four investor conferences in September

Geron Corporation today announced that the company will present updates of its product development programs at four investor conferences in the month of September.

31 Aug 2009

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care clinic provider in the U.S., today announced the availability of seasonal flu vaccinations and urged Americans to protect themselves early against the flu. CVS/pharmacy and MinuteClinic are divisions of CVS Caremark (NYSE: CVS), the largest provider of prescriptions in the country.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

Blue Cross Blue Shield of Arizona (BCBSAZ) announced today that it will cover the H1N1 vaccine for all BCBSAZ members in addition to its regular coverage of a seasonal flu shot.

29 Aug 2009

Health experts appeal for vaccines to be added to national immunization programs

During a recent three-day Asian Vaccine Conference, health experts appealed to countries to add "under-utilised vaccines such as those of pneumococcal, haemophilus influenzae type-b (Hib), and rotavirus" into national immunization programs, the Nation reports.

29 Aug 2009

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. The agreement will be executed after the public notice period.

28 Aug 2009

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.

28 Aug 2009

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

Omron Healthcare Co., Ltd. announced on August 28 a new sales milestone for blood pressure monitors: 100 million units sold worldwide. The first Omron digital blood pressure monitor was launched in 1973 and since then, Omron Healthcare has introduced more than 100 models used in more than 100 countries around the world.

28 Aug 2009

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.

28 Aug 2009

Vaccine News and Research

Latest Vaccine News and Research

Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

GenoCAD project receives financial support from NSF

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

Gates Foundation appoints new HIV program head

H1N1 cases on decline in Southern Hemisphere, WHO says

Stanford University starts recruiting participants for swine flu vaccine clinical trial

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Walgreens to provide flue shots faster and easier this season

Merck undergoes restructuring after Schering-Plough merger

Geron to present updates on product development programs at four investor conferences in September

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

Members of the Blue Cross Blue Shield of Arizona to receive coverage for H1N1 vaccine

Health experts appeal for vaccines to be added to national immunization programs

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in